Medical Device News Magazine

SABIC Reports Successful Step Towards Creating Circular Polymers Based On Advanced Recycling of Used Medical Plastic

Collaboration with dialysis department at Jessa Hospital, Belgium, in proof-of-concept pilot project. Project has shown that non-contaminated used medical plastic can be repurposed for advanced recycling and subsequent production of medical grade polymers as part of SABIC’s TRUCIRCLE™ portfolio. The pilot project could be translated into other regions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

SABIC

SABIC, a global leader in the chemical industry, has successfully demonstrated the feasibility of recycling used medical plastic back into the medical materials stream. The project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium. Serving as a pilot proof-of-concept, used medical plastic generated at Jessa’s hospital was converted to pyrolysis oil in an advanced recycling process, delivering circular feedstock for SABIC’s production of TRUCIRCLE™ polymers in medical grade quality with same performance, purity and physiological safety as virgin-based medical grade polymers. This is indispensable for medical approvals by regulators.

Lada Kurelec, General Manager, Polymers Technology & Innovation at SABIC, states:

“Working with Jessa Hospital has been an immensely rewarding experience, where we learned how individual belief in circularity can mobilize industry to work together. I value how this collaboration enabled creation of an ecosystem to collect and recycle non-contaminated medical waste in a very short time. Thanks to this collaboration, we are creating a certified circular TRUCIRCLE™ polymer portfolio able to serve the healthcare market. We are inviting other players in the value chain and in other regions to join us and Jessa in this ground-breaking initiative to accelerate the circularity of plastics in the medical industry.”

Advanced recycling technology and the vast experience gained through its TRUCIRCLE™ solutions put SABIC in a strong position to provide a circular solution designed to help Jessa Hospital reduce the environmental footprint of its medical products by avoiding their incineration after use. Approximately 85% of the used medical plastic generated at the hospital is not contaminated and therefore requires no specialized treatment. This allows it to be repurposed as feedstock for advanced recycling and subsequent production of high-quality medical grade polymers, saving virgin raw material and contributing to a more circular medical economy.

Karl Zwinnen, Project Engineer at Jessa adds:

“We are very pleased with the advanced and circular recycling approach enabled by SABIC to improve our medical waste management. The setup of an efficient collection system for used medical plastic has met with strong support among our medical and healthcare staff. Besides contributing to enhanced sustainability and circularity, the solution also has an enormous potential for reducing our disposal costs. We look forward to implementing it across all Jessa locations.”

As a result of this successful pilot project, SABIC is currently in the process of actively engaging partners to scale up operations and create a fully closed-loop recycling model for used medical plastic in larger volumes. Furthermore, there is the potential to initiate other similar pilot projects in other countries including the United States.

Circular Materials

SABIC’s certified circular materials are produced using mass balance accounting according to the International Sustainability & Carbon Certification (ISCC) PLUS program, which defines a set of transparent rules for tracking the material flow across complex supply chains from the feedstock to final applications. The resulting certified circular polymers form part of the company’s TRUCIRCLE™ portfolio and services.

TRUCIRCLE™ Portfolio

SABIC’s TRUCIRCLE™ portfolio and services include certified circular polymers as well as design for recyclability, mechanically recycled products, certified renewable polymers from bio-based feedstock, and closed loop initiatives to recycle plastic back into high-quality applications and help prevent valuable used plastics from becoming waste.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”